The Applications of Bioprinting with Alpha & Omega...
Life Sciences Research
3Dynamic bioprinting technology has been designed to precisely deposit multiple layers of hydrogels seeded with cells to produce tissue structures in 3D. These tissues are ideal for cancer, stem cell and regenerative medicine research. Scientists can also print cells in 2D format for high-throughput studies. Researchers can also study the interactions of different cells, molecules and materials in both 2D and 3D environments by bioprinting different materials together. For instance, different species of bacteria can be printed in different orientations relative to each other to study their interactions with one another.
By making tissues using bioprinting, our technology can be used to bioprint cells and subsequently produce tissues suitable for diagnostic medical research. With further research, 3D printed tissues can eventually be used for human transplantation. The first 3D bioprinted human tissue systems will likely be bone interface support tissues.
Bone Tissue Engineering
Bone engineering is a useful aspect of 3D bioprinting technology which is able to produce the exact shape of a structure, with osteoconductive biocompatible materials which are both durable and regenerative. The artificial bones bioprinted are capable of fusing with a patient’s natural bones over time with no complications. In order to start the process of bioprinting bones, we have engineered a unique new material made from a combination of gelatin, agarose, collagen alginate and calcium phosphate extra cellular matrix which can be used to engineer bone tissues systems.
Bioprinting in its first instance can be used to speed up and lower the cost for drug development and testing. Instead of developing and screening drugs using traditional, tedious, slow and expensive methods, pharmaceutical companies can now produce tissues on demand. By using 3Dynamic systems high precision, automation and versatility then representative tissues can be fabricated and used to develop and screen drugs. These companies and researchers can now use a single system for different applications without the need to purchase new systems. Pharma companies can also use our technology to create organ on a chip to better represent human specific tissues systems for drug testing.